Allovectin-7 (velimogene aliplasmid) - AnGes MG, Brickell
Vical: Q2 2013 Results (Vical) - Aug 2, 2013 - Anticipated top-line data from P3 registration trial for metastatic melanoma in Aug 2013 
Anticipated P3 data: top line • Melanoma
http://www.vical.com/investors/news-releases/News-Release-Details/2013/Vical-Reports-Second-Quarter-2013-Financial-Results-Projects-Phase-3-Data-Release-in-August-and-Establishes-Quiet-Period/default.aspx
 
Aug 2, 2013
 
.